3.5. Analysis.
Comparison 3 Interleukin‐2 receptor antagonist (IL‐2 RA) versus monoclonal antibody, Outcome 5 Post‐transplantation lymphoproliferative disorder.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.